Overview

Specifications

Reagent

INTERFERin®

Molecule delivered

siRNA, miRNA (microRNA), and other oligonucleotides: pre-miRNA, mimic miRNA, antimiR…

Applications

Transfection of siRNA and other oligonucleotides

Cell types

Adherent and suspension cells

Number of transfections

1 ml of INTERFERin® is sufficient to perform 500-1000 transfections in 24-well plates.

Storage

Store INTERFERin® at 5 °C ± 3°C.
Expiry date is indicated in the certificate of analysis (available in "My account") and on the product.


Summary

INTERFERin® provides very high silencing efficiency already at 1 nM siRNA and can be used in a wide variety of adherent and suspension cells. Using low concentration of siRNA avoids off-target effects, and its gentle mode of action ensure more robust data and excellent cell viability. Easy to use thanks to its compatibility with serum and antibiotics, INTERFERin® is also perfectly suited for transfection of miRNA and other oligonucleotides like pre-miRNA, mimic miRNA, antimiR….

Ordering information

Reference NumberAmount of reagent
101000036INTERFERin® 0.1 mL
101000028INTERFERin® 1 mL
101000016INTERFERin® 5 x 1 mL

Description

Less siRNA, less off-target effects

Several publications show that transfecting low siRNA concentrations avoids off-target effects. Indeed, these unwanted non specific side-effects are observed when transfecting siRNA at high concentrations (1,2). Hence, the reliability of the experimental data can be increased by using as little siRNA as possible. This is why INTERFERin® has been specifically designed to provide high silencing efficiency using low siRNA concentrations.
INTERFERin®-mediated delivery of 1 nM of a specific siRNA shows selective and highly efficient knockdown of gene expression, while a competitor (L2K) needs at least 10 nM siRNA to reach 50% silencing efficiency (Fig. 1).

INTERFERin - Silencing

Fig. 1: INTERFERin® only requires 1 nM siRNA for efficient gene silencing. 3LL cells stably expressing firefly luciferase were transfected with an anti-Luc siRNA using INTERFERin® or competitor L2K according to the manufacturer’s recommendation. Luciferase expression was measured after 48 h using a conventional assay. No inhibition was observed with control siRNA.

Amazingly, 50% silencing is still achieved at 10 pM siRNA (Fig. 2).

INTERFERin - Inhibition

Fig. 2: INTERFERin® is highly efficient even at extremely low siRNA concentration. A549-GL3Luc cells were transfected in the presence of serum with decreasing concentrations of an anti-Luc siRNA using INTERFERin®. Luciferase expression was measured after 48 h using a conventional assay. No inhibition was observed with control siRNA.

Transfection of 1 nM siRNA targeting endogenous lamin A/C with INTERFERin® drastically reduces lamin gene expression to barely detectable level (Fig. 3).

INTERFERin - Gene silencing

Fig. 3: Transfection of 1 nM siRNA with INTERFERin® results in efficient and specific gene silencing. CaSki cells were transfected with 1 nM lamin A/C siRNA using INTERFERin®. After 48 h, lamin A/C silencing efficiency was determined by immunofluorescence microscopy.

1. Birmingham, A. et al., (2006) Nature Methods, Vol.3, No3, 199-204
2. Caffrey, D. et al., (2011) PLoS One. 2011;6(7):e21503. Epub 2011 Jul 5.

Suitable for miRNA transfection

Transfection of microRNA (miRNA) oligonucleotides is increasingly being used to analyze biological effects of specific miRNAs on cell function. INTERFERin® is the reagent of choice for delivering miRNA, miRNA mimics or pre-miRNAs.
INTERFERin® is the latest generation siRNA & miRNA transfection reagent, especially designed for high transfection efficiency in a wide variety of cells, resulting in high gene silencing or stimulation of gene expression. Indeed, some miRNA are also known to induce gene expression by association with the promoter of the gene of interest. For example, INTERFERin®-mediated delivery of miR-373 leads to a 3 fold increase in E-Cadherin expression (Fig. 4).

INTERFERin - miRNA transfection

Fig. 4: Transfection of miR-373 with INTERFERin® enhances E-cadherin expression. PC-3 cells were seeded in a 6-well plate and transfected with miR-373 (25 nM) using 8 µl per well of INTERFERin®. 72h after transfection, E-cadherin mRNA expression level was determined by RT-qPCR. The assay was normalized with the HPRT-1 gene expression.

The cationic components of INTERFERin® require very little oligonucleotide amount, resulting in a gentle transfection process. In addition, the easy and robust protocol ensures reproducible results. Oligonucleotides like miRNA can be transfected with small quantities of INTERFERin® resulting in strong gene silencing or stimulation of gene expression. Whatever the concentration of INTERFERin® used, the effect stays approximately the same making INTERFERin® an economical reagent. For example, the fold change using different volume of INTERFERin® is always between 1.5 and 1.8 (Fig. 5).

INTERFERin - Quantification

Fig. 5: INTERFERin® is already efficient at very low amounts. PC-3 cells were seeded in a 6-well plate and transfected with miR-373 (10 nM) using 4, 6 or 8 µl per well of INTERFERin®. 72h post-transfection, E-cadherin expression was analyzed by Western Blot. The assay was normalized using β-actin expression. The quantification was expressed by taking the control situation as reference.

High transfection efficiency associated with high cell viability makes INTERFERin® the reagent of choice for generating relevant data for scientific publications. Indeed, the number of publications using INTERFERin® for miRNA and miRNA related molecules has been exponentially growing since its launch (Fig. 6).

INTERFERin - Number of publication

Fig. 6: INTERFERin® is involved in an increasing number of publication about miRNA transfection.

Over 90 % gene silencing

For many adherent cell lines or primary cells, 1 nM siRNA is sufficient to obtain more than 90 % gene silencing. For suspension cell lines, 80 % silencing can still be reached by INTERFERin® using 5 nM siRNA (Table 1).

INTERFERin - Table silencing

Table 1: Successfully transfected cell lines and silencing efficiencies obtained with INTERFERin®.

Specific conditions for various cell lines are available in our Polyplus-transfection Database.

Excellent cell viability

When it comes to cell viability, INTERFERin® outperforms other transfection reagents. 48 h after transfection with 1 nM siRNA, cells transfected with INTERFERin® appear healthy, while toxicity is clearly observed with reagent S (Fig. 7).

INTERFERin - Comparison of cell morphology

Fig. 7: INTERFERin® is extremely gentle on cells, as shown in this comparison of cell morphology 48 h after siRNA transfection using INTERFERin® or competitor reagents. A549-GL3Luc cells were transfected in the presence of serum with 1 nM Luciferase siRNA using INTERFERin® or competitors S or H according to the manufacturer’s protocol.

Easy standard protocol

INTERFERin® is ready to use and the protocol is straightforward. A starting concentration of 1 nM siRNA ensures silencing of most genes in most cell types (Fig. 8).
INTERFERin® is compatible with both serum and antibiotics, hence avoiding any time consuming washes and medium changes; furthermore INTERFERin® can be left on the cells without any adverse effects.

INTERFERin - Protocol

Fig. 8: INTERFERin® Protocol

Take a look at our Expert Tips in Genetic Engineering and Biotechnology News .

 

Video: siRNA transfection using INTERFERin®

FAQ

If you have any questions regarding INTERFERin®, please visit our dedicated Frequently asked questions or contact us.

Applications

Our INTERFERin® reagent is perfectly suited to perform RNA interference experiments, which correspond to the specific inhibition of gene expression promoted by siRNA. siRNAs are gene specific complementary double-stranded RNA oligonucleotides present in the cytoplasm of plants, worms and mammalian cells, and can be efficiently transfected into cells with INTERFERin®.

Read more…

Quality

Every batch of INTERFERin® is tested in house in a transfection assay on A549-Luc cells, constitutively expressing the Luciferase gene. The silencing efficiency obtained using 1 nM siRNA and INTERFERin® for each batch is indicated on the Certificate of Analysis.

Testimonials

“I prefer INTERFERin [vs two competitors]. Awesome product with very competitive price.”
 Latonia T.S., Winship Cancer Institute of Emory University, United States 
  
“Cells seemed to be less stressed compared to [competitor]. I observed less apoptotic cells and will order INTERFERin for my next experiments. Thanks again for the trial sample. Best wishes, Anja”
 Anja B., Goethe Universität Frankfurt, Germany 
  
“I use your INTERFERin siRNA reagent in primary human Macrophages with terrific results.”
 Jason H., Emory University, United States 
  
“This is far better than some other well known products in transfecting siRNA.”
 Venkateswarlu K., Swansea University, United Kingdom 
  

Protocol

In order to download a product protocol or a certificate of analysis, please create an account on Polyplus ® Portal .

Why would you need to create an account?

In this personal area you will have access to:

  • Product Protocols
  • Certificates of Analysis
  • Exclusive webinars/articles
  • And surprise features!

Other files

Related blog posts

Bibliography

Order by :  
Found 1262 results :
Cell Linein vitro
in vivo
Delivered MoleculeReagentResults & Citations
C3H/10T1/2in vitroDNA, siRNAINTERFERin, jetPRIME
Son Y. et al. (2022)

Metabolism 130, 155159
REEP6 knockout leads to defective β-adrenergic signaling in adipocytes and promotes obesity-related metabolic dysfunction
More details
3T3-L1in vitrosiRNAINTERFERin
Berthou, F. et al. (2015)

Mol Endocrinol 29, 1025-36
The Tpl2 Kinase Regulates the COX-2/Prostaglandin E2 Axis in Adipocytes in Inflammatory Conditions
More details
A549, H1299in vitrosiRNAINTERFERin
Yan M. et al. (2022)

Mol Biol Rep 49, 2607-2618
High expression of HOXB3 predicts poor prognosis and correlates with tumor immunity in lung adenocarcinoma
More details
BONin vitrosiRNAINTERFERin
Bretou, M. et al. (2014)

Mol Biol Cell 25, 3195-209
Cdc42 controls the dilation of the exocytotic fusion pore by regulating membrane tension
More details
MDA-MB-231, MDA-MB-436in vitrosiRNAINTERFERin
Chadelle L. et al. (2022)

Cancer Lett 526, 112-130
PKCθ-mediated serine/threonine phosphorylations of FAK govern adhesion and protrusion dynamics within the lamellipodia of migrating breast cancer cells
More details
Mouse primary VSMCs, Mouse peritoneal macrophagesin vitrosiRNAINTERFERin
Chen, Y. X. et al. (2015)

Biochem Biophys Res Commun 465, 732-8
The Sirt1 activator SRT1720 attenuates angiotensin II-induced atherosclerosis in apoE(-)/(-) mice through inhibiting vascular inflammatory response
More details
BV-2in vitrosiRNAINTERFERin
Wang Y. et al. (2022)

Theranostics 11, 9623-9651
A novel lncRNA linc-AhRA negatively regulates innate antiviral response in murine microglia upon neurotropic herpesvirus infection
More details
Human primary foreskin keratinocyesin vitrosiRNAINTERFERin
Erasmus, J. C. et al. (2015)

Cell Signal 27, 1905-13
Cooperation of distinct Rac-dependent pathways to stabilise E-cadherin adhesion
More details
LNCaPin vitrosiRNAINTERFERin
Kim DH. et al. (2022)

Phytother Res ,
Antitumor mechanism of combination of Angelica gigas and Torilis japonica in LNCaP prostate cancer cells via G1 arrest and inhibition of Wnt/β-catenin and androgen receptor signaling
More details
SK-OV-3, A2780, A549, IGROV1-R10, MSTO-211Hin vitrosiRNAINTERFERin
Gloaguen, C. et al. (2015)

J Med Chem 58, 1644-68
First evidence that oligopyridines, alpha-helix foldamers, inhibit Mcl-1 and sensitize ovarian carcinoma cells to Bcl-xL-targeting strategies
More details